These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11890469)

  • 1. Toxicogenomics, drug discovery, and the pathologist.
    Boorman GA; Anderson SP; Casey WM; Brown RH; Crosby LM; Gottschalk K; Easton M; Ni H; Morgan KT
    Toxicol Pathol; 2002; 30(1):15-27. PubMed ID: 11890469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.
    Morgan KT; Pino M; Crosby LM; Wang M; Elston TC; Jayyosi Z; Bonnefoi M; Boorman G
    Toxicol Pathol; 2004; 32 Suppl 1():13-25. PubMed ID: 15209399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and future applications of microarrays in toxicological research.
    Gant TW
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):599-608. PubMed ID: 17696809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic importance of research support through pathology.
    Cockerell GL; McKim JM; Vonderfecht SL
    Toxicol Pathol; 2002; 30(1):4-7. PubMed ID: 11890474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of toxicogenomics.
    Hamadeh HK; Amin RP; Paules RS; Afshari CA
    Curr Issues Mol Biol; 2002 Apr; 4(2):45-56. PubMed ID: 11931569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
    Waters MD; Jackson M; Lea I
    Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workgroup report: Review of genomics data based on experience with mock submissions--view of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee.
    Leighton JK; Brown P; Ellis A; Harlow P; Harrouk W; Pine PS; Robison T; Rosario L; Thompson K
    Environ Health Perspect; 2006 Apr; 114(4):573-8. PubMed ID: 16581548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
    Yang Y; Blomme EA; Waring JF
    Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics research consortium sails into uncharted waters.
    Medlin J
    Environ Health Perspect; 2002 Dec; 110(12):A744-6. PubMed ID: 12460811
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicogenomics in biomarker discovery.
    Decristofaro MF; Daniels KK
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.